IMS forecasts worldwide pharmaceutical sales to increase 4.5%–5.5%, in 2009, the same as 2008’s growth, to more than $820 billion. Oncology products will drive growth, with sales expected to increase 15%–16%. Also driving sales growth will be HIV therapies, which are forecasted to grow 13%–14%, and biologics, which are expected to grow 11%–12%. Sales of […]
For most people, the word electrochemistry may conjure up the image of the humble pH meter, but this field of laboratory analysis is actually very multi-faceted, with numerous distinct techniques. Fundamentally, these techniques all measure aspects of chemical reactions that involve the transfer of electrons in solution. This transfer of electrons can be measured as […]
Company Announcements Syrris established a subsidiary office in Japan earlier this year. In September, Prosonix, a provider of ultrasonic process chemistry solutions, announced a marketing partnership with Syrris for Prosonix’s Sonolab lab-scale equipment, which employs a transducer-based design. ThalesNano announced in September the closing of an investment of $3.3 million. In October, Micronit Microfluidics, FutureChemistry […]
Northbrook, IL 10/20/08—IDEX has acquired Semrock, a provider of optical filters for biotech and analytical instruments in the life sciences markets, for approximately $60 million in cash. Semrock generates annual revenues of approximately $21 million and is based in Rochester, New York. “Their expertise enables the continued expansion of our core capabilities in integrated fluidic […]
Hopkinton, MA 10/29/07; Washington, DC 10/30/08—Caliper Life Sciences has agreed to sell its Pharmaceutical Development & Quality Analysis (PDQ) product line to SOTAX for approximately $13.8 million in cash and $2 million of assumed liabilities. The PDQ line consists of the TPW3 tablet processing workstation, the APW3 active ingredient processing workstation, the MultiDose G3 dissolution […]
Research published in the Journal of the American Medical Association (JAMA) this month indicates that regulatory actions related to safety concerns have been issued for 23.6% of the biological medicinal products approved for sale in the US and EU between January 1995 and June 2008. Of the 174 biologicals approved for sale in the regions […]
Santa Clara, CA 10/22/08—Affymetrix has announced that its founder, Chairman and CEO Stephen P.A. Fodor, PhD, will step down at the end of the year. Replacing Dr. Fodor will be President Kevin M. King, who will become CEO and a member of the Board of Directors on January 1, 2009. Dr. Fodor will become full-time […]
Company Announcements Geneva Bioinformatics named GE Healthcare Life Sciences as its Latin American distributor. Abbott has made an additional $20 million investment in Ibis Biosciences (see IBO 2/15/08), bringing its equity holding to 18.6%. Thermo Fisher Scientific integrated its MS instrumentation with Genedata’s Genedata Expressionist software for metabolomics applications. The Thermo Fisher Scientific Biomarker Research […]
Carlsbad, CA 10/21/08—Invitrogen has announced the acquisition of VisiGen Biotechnologies, a developer of single-molecule sequencing technology, for $21 million in cash. VisiGen’s technology utilizes fluorescence resonance energy transfer technology and massively parallel arrays. Invitrogen Chairman and CEO Gregory Lucier commented that Invitrogen acquired VisiGen for its intellectual property and for the company’s strength in enzymology […]
A total of $29 billion was spent on R&D in Canada in 2007. The private sector represented 48% of funding and performed 54% of the country’s research activities. The second-largest investor in R&D was the federal government, which accounted for 19% of research funding. Fifty-two percent of 2007 federal government R&D investments went to universities […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
